Track GDTC and 10,000+ stocks
Create a free account to build watchlists, compare peers, and value any stock.
- Build and track watchlists
- Compare against peers
- Earnings & price alerts
No credit card required
Create a free account to build watchlists, compare peers, and value any stock.
No credit card required
GDTC - CytoMed Therapeutics Limited Ordinary Shares (GDTC) has a earnings per share of $0.00, up 100.0% over the past year.
Latest EPS (Actual)
$0.00
Beat Rate
12.5%
Most Recent
Beat
| Date | Estimated EPS | Actual EPS | Result | Surprise % |
|---|---|---|---|---|
| Jun 2026 | -$0.04 | $0.00 | Beat | +100.00% |
| Oct 2025 | -$0.04 | -$0.19 | Miss | -375.00% |
| Apr 2025 | -$0.04 | -$0.12 | Miss | -200.00% |
| Nov 2024 | -$0.04 | -$0.04 | Meet | +0.00% |
| Sep 2024 | -$0.04 | -$0.09 | Miss | -125.00% |
| May 2024 | -$0.04 | -$0.04 | Meet | +0.00% |
| Feb 2024 | -$0.05 | -$0.05 | Meet | +0.00% |
| Nov 2023 | -$0.06 | -$0.08 | Miss | -33.33% |
Earnings per share (EPS) is a company's net profit divided by its number of outstanding shares. It shows how much profit is attributable to each share and is one of the most closely watched gauges of profitability.